Cipla
Indian multinational pharmaceutical company
Follow Cipla on Notably News to receive short updates to your email — rarely!
| April 2024 | Cipla acquired Ivia Beaute Pvt Ltd's cosmetics and personal care distribution and marketing business for ₹130 crore. |
| January 2024 | Samina Hamied resigned from her position as Executive Vice Chairperson of Cipla, while continuing to serve as a non-executive director subject to rotational retirement. |
| September 2023 | Cipla South Africa announced the acquisition of Actor Pharma, a Midrand-headquartered healthcare products manufacturer. |
| 2022 | Cipla reported having over 25,000 employees in their annual report, with women comprising 14.3% of the workforce. |
| July 2020 | Cipla introduced Remdesivir under the brand name CIPREMI in India, obtaining a voluntary licensing agreement with Gilead Sciences and DCGI approval for emergency use in treating critically ill COVID-19 patients. |
| 2019 | Cipla entered digital therapeutics by partnering with Wellthy Therapeutics in India and Brandmed in South Africa. |
| September 2015 | Cipla acquired InvaGen Pharmaceuticals and Exelan Pharmaceuticals, two American pharmaceutical companies, for 555 million dollars. |
| 2013 | Cipla acquired Cipla-Medpro in South Africa, which was the country's third-biggest pharmaceutical company at the time. |
This contents of the box above is based on material from the Wikipedia article Cipla, which is released under the Creative Commons Attribution-ShareAlike 4.0 International License.